Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether injections of Botulinum toxin type A into
muscles of the leg(s) or of leg(s) and one arm are safe in treating children/adolescents (age
2-17 years) long-term with increased muscle tension/uncontrollable muscle stiffness
(spasticity) due to cerebral palsy.
Phase:
Phase 3
Details
Lead Sponsor:
Merz Pharmaceuticals GmbH
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA